Biodistribution and metabolism of C-11-labeled Kendine 91 in mice and rats.
Gómez-Vallejo V, Martín A, Aginagalde M, San Sebastian E, Padro D, Cossio FP, Llop J.
Appl. Radiat. Isot. 2012; 70: 2545-2551. FI: 1.172 (Q2).
Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?.
Ballabio E, Armesto M, Breeze CE, Manterola L, Arestin M, Tramonti D, Hatton CSR, Lawrie CH.
Blood Cancer Journal. 2012; 2: -0. FI: 0.000 (Q0).
Changes in Fluorescent Emission Due to Non-covalent Interactions as a General Detection Procedure for Thin-Layer Chromatography.
Cebolla VL, Mateos E, Garriga R, Jarne C, Membrado L, Cossio FP, Galvez EM, Matt M, Delgado-Camon A.
Chem. Phys. Chem. 2012; 13: 291-299. FI: 3.412 (Q1).
Computational insights on the possibility of tri-coordinated cisplatinated adducts with protein models.
Ortega-Carrasco E, Cossio FP, Lledos A, Marechal JD.
J. Inorg. Biochem. 2012; 117: 230-236. FI: 3.354 (Q1).
Densely substituted unnatural L- and D-prolines as catalysts for highly enantioselective stereodivergent (3+2) cycloadditions and aldol reactions.
Conde E, Bello D, De Cozar A, Sánchez M, Vázquez MA, Cossio FP.
Chem. Sci. 2012; 3: 1486-1491. FI: 7.525 (Q1).
Effects of Different Types of Hsp90 Inhibitors in Pancreatic and Colorectal Cancer Cell Lines.
Mayor-López L, De Torre C, Tristante-Barrenechea E, Carrasco-García E, Garacía-Morales P, Saceda M, Carballo F, Martínez-Lacaci I.
Eur. J. Cancer. 2012; 48: 231-232. FI: 5.536 (Q1).
SENEC. Functions and organisation of a neuro-oncology committee in hospitals with a neurosurgery service.
Arrazola M, Bollar A, Sampron N, Ruiz I, Egaña L, Querejeta A, Villanua J, Liceaga G, Caballero MC, Urtasun M, Urculo E.
Neurocirugía. 2012; 23: 151-156. FI: 0.540 (Q4).
mRNA In Situ Hybridization (HistoSonda): A New Diagnostic Tool for HER2-Status in Breast Cancer-A Multicentric Spanish Study.
Bernet L, Martínez M, Castera C, Cano R, Sevilla F, Alba J, De Dios J, Córdoba A, García-Caballero T, Hardisson D, De Francisco-Hernández JM, Lazaro JM, Polo L, Riu F, Rezola R, Rojo F, Ruiz I, Hernandiz A, De la Cámara JM, Coupe VM.
Diagn. Mol. Pathol. 2012; 21: 84-92. FI: 2.257 (Q2).
Neuronavigation in the surgery for atlantoaxial instability: “the spinal shift”.
Sampron N, Arrazola M, Urculo E.
Neurocirugía. 2012; 23: 44-45. FI: 0.540 (Q4).
Regioselective Preparation of Benzo[b]furans from Phenols and alpha-Bromoketones.
Arias L, Vara Y, Cossio FP.
J. Org. Chem. 2012; 77: 266-275. FI: 4.450 (Q1).
Selective “One-Pot” Synthesis of Functionalized Cyclopentenones.
Varea T, Alcalde A, López de Dicastillo C, Ramirez de Arellano C, Cossio FP, Asensio G.
J. Org. Chem. 2012; 77: 6327-6331. FI: 4.450 (Q1).
Study of the Anticancer Properties of Tin(IV) Carboxylate Complexes on a Panel of Human Tumor Cell Lines.
Rocamora-Reverte L, Carrasco-García E, Ceballos-Torres J, Prashar S, Kaluderovic GN, Ferragut JA, Gómez-Ruiz S.
ChemMedChem. 2012; 7: 301-310. FI: 3.151 (Q2).
Synthesis of C-11-labeled Kendine 91, a histone deacetylase inhibitor.
Aginagalde M, Gómez-Vallejo V, Vara Y, Cossio FP, Llop J.
Appl. Radiat. Isot. 2012; 70: 2552-2557. FI: 1.172 (Q2).
The Quinoline Imidoselenocarbamate EI201 Blocks the AKT/mTOR Pathway and Targets Cancer Stem Cells Leading to a Strong Antitumor Activity.
Ibanez E, Agliano A, Prior C, Nguewa P, Redrado M, González-Zubeldia I, Plano D, Palop JA, Sanmartín C, Calvo A.
Curr. Med. Chem. 2012; 19: 3031-3043. FI: 4.859 (Q1).
